DEVA INSIGHTS & INDUSTRY NEWS

Why Is the "Concentration Arms Race" Losing Effectiveness? In 2026, facial skincare formulation engineering has shifted from "single-ingredient stacking" to "pathway synergy." According to Mintel's 2026 Global Efficacy Skincare Consumer Insights, 61% of mature consumers list "gentle tolerance + visible improvement" as their primary repurchase driver, while only 19% are willing to accept irritation risks for "high concentration" claims . Niacinamide (NA), as a classic multi-ef

One of the earliest — and most consequential — decisions a facial skincare brand makes is whether to develop a proprietary formula from scratch or adapt an existing stock base. Get it wrong, and you face either an unsustainable cost structure or a product indistinguishable from a dozen competitors. Get it right, and you build a defensible brand asset with predictable margins. This guide frames the core trade-offs clearly, drawing on contract manufacturing practice and regulat

Nearly every barrier repair serum launched in the last two years is built on one of three systems: ceramides, panthenol, or Centella Asiatica extract. They are frequently positioned as competitors. In formulation terms they do three different jobs, and the choice between them is decided by the claim you want to make and the skin type you are selling to. Here is how each system works, what the clinical data actually supports, and what changes in your OEM brief depending on whi

Infant skin is structurally distinct from adult skin — thinner, with a less mature barrier, higher transepidermal water loss (TEWL), and a still-developing acid mantle. For brand owners and procurement managers entering the baby personal care category, these physiological realities are formulation constraints, not marketing talking points. This guide breaks down the core logic behind baby cream and baby wash development, helping you make informed decisions when briefing a con

How Should an OEM Rank Anti-Aging Ingredients? An OEM should rank anti-aging ingredients on four axes that buyers actually weigh: strength of clinical evidence, tolerance in use, effective loading concentration, and cost per kilogram at that loading. Ranked on evidence alone, retinol leads. Ranked on tolerance, peptides and bakuchiol lead. Ranked on cost per kilogram, bakuchiol and peptides sit below retinol at low loading and well below Pro-Xylane at effective loading. None

In 2026, the cosmetics OEM market has evolved from a "capacity dividend era" into a "compliance and efficiency deep-water zone." According to BCG's 2026 China Beauty Supply Chain Evolution Report, among brand manufacturers' core criteria for selecting OEM partners, the weighting of "price" has declined from 41% in 2020 to 18%, while "compliance stability," "batch consistency," "supply chain resilience," and "joint R&D capability" collectively account for over 67% . On the sur

Skincare Niche Segments Reality: From "Blue Ocean" to "Red Ocean" In 2026, the global skincare market reaches $215.4 billion, yet homogeneous competition has intensified . Facial care products account for 82.75% of the skincare industry's market share , yet 67% of new products fail within their first year due to lack of differentiation. Brands face a triple dilemma: Ingredient saturation: Overuse of hero actives like niacinamide, hyaluronic acid, and peptides Claim convergenc

Why Packaging Selection Determines Product Success or Failure In 2026, packaging has evolved from a "visual container" to an "efficacy preservation chamber." According to Euromonitor's 2026 Beauty Packaging Trends Report, 41% of active ingredient deactivation stems from inadequate packaging seal integrity or material migration . Selecting the wrong packaging not only triggers complaints and returns but can directly cause NMPA compatibility filing rejections. Based on the late

Clean Beauty Enters the "Deep Water Zone": Safety and Efficacy Are No Longer Mutually Exclusive In 2026, "Clean Beauty" has evolved from a marketing buzzword into a dual baseline for R&D and compliance. According to WGSN's 2026 Global Beauty Consumer Insights, 74% of Gen Z and Millennial consumers rank "ingredient transparency/no controversial additives" alongside "clinical-grade efficacy" as their top purchase drivers, and they are willing to pay a 22% premium for the "safe